IDEXX posts lower Q1 earnings, cuts full-year outlook

IDEXX Laboratories Inc. (Nasdaq: IDXX), the Westbrook maker of veterinary diagnostics, veterinary software and water testing, on Wednesday posted lower first-quarter earnings than a year ago and cut its outlook for 2022 due to the strengthening U.S. dollar, higher interest rates and the war in Ukraine.

Quarterly earnings totaled $193.9 million, or $2.27 a share, down from $204.3 million, or $2.35 a share, for the same period in 2021. The results, while lower, still surpassed Wall Street expectations of $2.25 a share, according to Zacks Investment Research. Read more

Related Posts

On the Record: Roux Institute’s Lars Perkins helps startups take off

Lars Perkins, a former software entrepreneur, Google executive and certified flight instructor who once flew planes for lifesaving “adventure philanthropy,” is managing...

28 November 2022

UNE to begin building new medical school at Portland campus

The University of New England is about to start a $93 million project to move the state’s only medical school from...

28 November 2022

Portland Planning Board recommends zoning changes for Roux Institute redevelopment

The Portland Planning Board is recommending that the city adopt zoning changes requested by the developers of a new graduate school...

22 November 2022